Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo

Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivo

miR-101–3p may play a therapeutic role in various tumours. However, its anti-tumour mechanism remains unclear, and a definitive strategy to treat tumour cells in vivo is lacking. The objective of this study was to investigate the inhibitory mechanism of miR-101–3p on tumour cells and to develop rele...

Full description

Bibliographic Details
Main Authors: Yifeng Luo, Gang Niu, Hui Yi, Qingling Li, Zhiqiang Wu, Jing Wang, Juan Yang, Bo Li, Yuan Peng, Ying Liang, Weiwei Wang, Zhenwei Peng, Xintao Shuai, Yu Guo
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Redox Biology
Subjects:
Ferroptosis
Nanomedicine
ROS
Proliferation
Apoptosis
TBLR1
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231721000562

Internet

http://www.sciencedirect.com/science/article/pii/S2213231721000562

Similar Items